DIA-LEAGUE. Agenda. Dr. Vivek Sundaram

Transcription

1 th : 03:00 p.m. to 09:15 p.m. Date: 5 April 2015 Venue: Connemara - Vivanta by Taj, Binny Road, Chennai India Clinical case vignettes Dr. Anand Moses (Moderator) 3:30 p.m. - 3:50 p.m. 1) Diabetic patient with recurrent hypoglycemia and Dr. Vivek Sundaram Dr. A. Panneerselvam 3.55 p.m p.m p.m p.m. 2) Newly diagnosed diabetic with very high level of Dr. Jayashree Gopal Dr. A. Panneerselvam 4.30 p.m p.m p.m p.m. DPP4 inhibitors and Cardiovascular Risk:what is the evidence? Dr. Pradeep John Promod Dr. S. Sridhar 5.05 p.m p.m p.m p.m. (FPG,PPG,HbA1c) with added benefit of tackling GV-the value added by Voglibose based triple therapy Dr. Vamsie Mohan Dr. S. Sridhar 5.40 p.m p.m p.m p.m. Snack Break 6.10 p.m p.m. Ambulatory glucose profiling-novel concept, promises improved diabetic patient outcomes Dr. J. S. Kumar Dr. R. Madhavan 6.35 p.m p.m. 6:55 p.m p.m. Dr. N. K. Narayanan Dr. R. Madhavan 7.10 p.m p.m. 7:30 p.m. - 7:40 p.m. Class Drug as an initial therapy fails For DPP4-15 minutes Dr. Muthu Kumaran Jayapaul 7:45 p.m. - 8:30 p.m. Against DPP4-15 minutes Dr. Samith Shetty New Frontiers in the Management of Diabetic Nephropathy Q&A Session Concluding remarks Dr. Suresh Sankarasubbaiyan Dr. Anand Moses (Moderator) 8.30 p.m p.m p.m p.m p.m p.m.

2 rd Timing: 5:00 pm to 9:45 pm Date: 23 August 2015 Venue: Hotel The Residency, 1076, Avinashi Road, Coimbatore , Tamil Nadu, India. 5:00 pm to 5:15 pm Intoduction Asian Society Dr. J. Giri (Moderator) PG.D Diabetes Care 5:15 pm to 5:30 pm 5:30 pm to 5:50 pm (FPG, PPG, HbA1c) with added benefit of tackling GV-the value added by Voglibose based triple therapy Dr. Joe George MBBS, DNB (Medicine), MD (General Medicine), DM (Endocrinology) Dr. R. Srinivasan MBBS, MD, CCST in Diab & Endocrionology MD, MRCP (UK) 5:50 pm to 6:20 pm Dr. Anish Ahamed K.M. MD (General Medicine), DNB (Endocrine), SCE (Endocrine), RCP (UK) Dr. K. Umakanthan MBBS, MD (General Medicine) 6:20 pm to 6:40 pm Clinical case vignettes 1) Diabetic patient with recurrent hypoglycemia and 2) Newly diagnosed diabetic with very high level of Dr. Premkumar A. MBBS, MD (Internal Medicine), DM (Endocrinology), DNB Dr. Anandkumar Annamalai D.Diab (WHO ZAGREB), MRCP (UK), SCE (UK), Mphil (Cambridge) Dr. K. Arun Karthik MBBS, F. Diab Dr. R. Suresh Prabu MBBS, MD (Internal Medicine), DNB Endocrinology 6:40 pm to 7:30 pm 7:30 pm to 8:00 pm Class Drug as an initial therapy fails For DPP4 15 minutes Against DPP4 15 minutes Dr. Sureshkumar P. Ph.D (Medicine Diabetes) Dr. R. Ceaser P.G Diploma In Diabetology Dr. R. Srinivasan MRCP (UK), CCST in Diabetes, Endocrinology & General Medicne Dr. Arun Karthik MBBS, F. Diab 8:00 pm to 9:00 pm DPP4 inhibitors and Cardiovascular Risk: What is the evidence? Dr. Shyam Mukundan P.G Diploma In Diabetology Dr. K. Umakanthan MBBS, MD (General Medicine) 9:00 pm to 9:30 pm Concluding remarks Dr. J. Giri (Moderator) PG.D Diabetes Care 9:30 pm to 9:45 pm

3

4 : 03:00 p.m. to 09:00 p.m. Date: 19 th April 2015 Venue: Hotel Vivanta by Taj, Gomti Nagar, Lucknow, Uttar Pradesh Dr. M. K. MITRA (Moderator) 3:30 p.m. to 3:50 p.m. Clinical Case Vignettes 1 Diabetic patient with recurrent hypoglycemia and Dr. Pankaj Aneja Dr. Alok Joshi 3:50 p.m. to 4:20 p.m. (FPG,PPG,HbA1c) with added benefit of tackling GV- Dr. Mukulesh Gupta Dr. Ashok Chandra 4:20 p.m. to 4:50 p.m. the value added by Voglibose based triple therapy Class Drug as an initial therapy fails (Discussion) For DPP4-15 minutes Against DPP4-15 minutes Dr. Anil Motta Dr. Veerendra Singh Dr. Jagdish Mulchandani 4:50 p.m. to 5:30 p.m. Clinical case vignettes 2 Newly diagnosed diabetic with very high level of Dr. Anil Kumar Bhatt Dr. Sharad Kumar 5:30 p.m. to 6:00 p.m. 6:00 p.m. to 6:30 p.m. Dr. Manoj Kumar Srivastava Dr. Ashok Chandra 6:30 p.m. to 7:10 p.m. Glycemic variability- Are we missing an important tool to monitor diabetes? Dr. Arun Pandey Dr. Ashok Chandra 7:10 p.m. to 7:40 p.m. DPP4 Inhibitors and CV risk what is the evidence? Dr. Navnit Agarwal Dr. Sharad Kumar 7:40 p.m. to 8:20 p.m. Concluding remarks, prize distribution for best team presentation of CCV and wrap up Asian Society 8:20 p.m. to 9:00 p.m.

5 st Date: 21 June 2015 Timing: 3:00 p.m. to 8:15 p.m Venue Hotel Radisson Blu,7 Wardha Road, Nagpur, Maharashtra (FPG, PPG, HbA1c) with added benefit of tackling GV-the value added by Voglibose based triple therapy Clinical case vignettes 1 Diabetic patient with recurrent hypoglycemia and Clinical case vignettes 2 Newly diagnosed diabetic with very high level of Class Drug as an initial therapy fails (Discussion) For DPP4-15 minutes Against DPP4-15 minutes Dr. Sunil Gupta (Moderator) 3:30 p.m. to 3:50 p.m. Dr. Vishal Bharadwaj Dr. Suneel Deshpande 3:50 p.m. to 4:20 p.m. Dr. Manoj Chadha Dr. Shankar Vasista 4:20 p.m. to 4:50 p.m. Dr. Ashish Dengra Dr. Suneel Deshpande 4:50 p.m. to 5:40 p.m. Dr. Yashpal Gogate Dr. Shankar Vasista 5:40 p.m. to 6:00 p.m. Dr. Sanjay Agrawal Dr. Nirmal Jaiswal 6:00 p.m. to 7:00 p.m. Dr. Pravin Kalvit Dr. Shankar Khobragade DPP4 Inhibitors and CV Risk - What is the evidence? Dr. M. P. Samal Dr. Nirmal Jaiswal 7:00 p.m. to 7:30 p.m. Gylcemic variability -Are we missing an important tool to monitor diabetes?" Dr. Sanjay Agrawal Dr. Shankar Khobragade 7:30 p.m. to 8:00 p.m. Concluding remarks and wrap up 8:00 p.m. to 8:15 p.m.